IP Library › Granted Patent US 10,266,609
Granted Patent B2
US 10,266,609 · App. 15/309,313 · Granted Apr 23, 2019

Immunomodulating beta-1,6-D-glucans

Inventors: James Michael Siedlecki (Burlington, MA); Gabriel Oscar Reznik (Bedford, MA); John James Kane (Cambridge, MA); Hua Miao (Newton, MA); Arthur F. Kluge (Lincoln, MA); Ifat Rubin-Bejerano (Newton, MA)
Assignee: Innate Biotherapeutics, LLC
C08B37/0024C07H3/06C07H5/04C07H13/04C07H15/04C07H15/18C07H15/203C07H15/26C07H19/044C07H19/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,609
App. No.
15/309,313
Granted
Apr 23, 2019
Kind
B2
Abstract

This invention relates to modifications of β-1,6-D-glucans, e.g., structures according to Formula (I), and the ability of these compositions to modulate an immune response.

Claims (71)

1. A compound having a structure according to the following general formula (I),

wherein

n is an integer from 1 to 18;

B is —CH 2 OH, —CHO, or —CO 2 H;

A is α and is:

(a) —OR, wherein R is alkenyl, alkynyl, aryl, heteroaryl, or heteroaliphatic;

(b) —SR, wherein R is alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heteroaliphatic;

(c)a 6-O-substituted-D-glucosamine (W),

 wherein

R′ is alkyl, aryl, or heteroaryl;

(d)a 6-O-substituted-C-glycoside (X),

 wherein

R 1 is H; and R 2 is alkenyl, alkynyl, or heteroaliphatic; or

R 2 is H; and R 1 is alkenyl, alkynyl, or heteroaliphatic;

and

a is 0, 1, 2, 3, 4, or 5

 wherein

R is H, alkyl, or aryl, and

azidoalkvl is an alkyl group comprising an azide moiety;

 wherein

A′ is alkyl, aryl, or heteroaryl; A″ is carboxy alkyl, carboxy aryl, or carboxy heteroaryl; carboxy alkyl represents a residue formed from an aliphatic amino acid; carboxy aryl represents a residue formed from an aromatic amino acid; and carboxy heteroaryl represents a residue formed from a heteroaromatic amino acid;

 wherein

A′ is alkyl, aryl, or heteroaryl; and aminoalkyl represents an alkyl group containing an amino moiety;

or

2. The compound of claim 1 , wherein group A is —SR.

3. The compound of claim 1 , wherein group A is —O(CH 2 CH 2 O)aCH 2 CH 2 N 3, wherein a is 0, 1, 2, 3, 4, or 5.

4. The compound of claim 1 , wherein group A is a 6-O-substituted-D-glucosamine (W),

5. The compound of claim 1 , wherein group A is

wherein R is H, alkyl, or aryl, and azidoalkyl is an alkyl group containing an azide moiety.

6. The compound of claim 5 , wherein R is unsubstituted alkyl or substituted alkyl.

7. The compound of claim 1 , wherein group A is

8. The compound of claim 7 , wherein A′ is alkyl or aryl; and

A″ is carboxy alkyl.

9. The compound of claim 1 , wherein group A is

10. The compound of claim 1 , wherein said compound has a structure according to formula (Ib),

wherein

n is an integer between 1-18, and

R is selected from alkyl, alkenyl, alkynyl, alkylene, alkynylene, aryl, and heteroaryl.

11. A compound having a structure according to formula (Ic)

wherein n is an integer between 1-18, and

R is alkyl.

12. A compound having a structure according to formula (Id),

wherein n is an integer between 1-18, and

R is alkyl.

13. A compound having a structure according to the following general formula (I),

wherein

n is an integer from 1 to 18;

B is —CH 2 OH, —CHO, or —CO 2 H;

A is:

(a) —SR, wherein R is alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heteroaliphatic;

(b) —O(CH 2 CH 2 O)aCH 2 CH 2 N 3, wherein a is 0, 1, 2, 3, 4, or 5;

(c) a 6-O-substituted-D-glucosamine (W),

 wherein

R′ is alkyl, aryl, or heteroaryl;

 wherein

R is H, alkyl, or aryl, and

azidoalkyl is an alkyl group comprising an azide moiety;

 wherein

A′ is alkyl, aryl, or heteroaryl; A″ is carboxy alkyl, carboxy aryl, or carboxy heteroaryl; carboxy alkyl represents a residue formed from an aliphatic amino acid; carboxy aryl represents a residue formed from an aromatic amino acid; and carboxy heteroaryl represents a residue formed from a heteroaromatic amino acid;

 wherein

A′ is alkyl, aryl, or heteroaryl; and aminoalkyl represents an alkyl group containing an amino moiety; or

(g) —O -alkyl, when B is —CHO, or —CO 2 H.

14. The compound of claim 13 , wherein A is β.

15. The compound of claim 13 , wherein group A is

wherein R is H, alkyl, or aryl, and azidoalkyl is an alkyl group containing an azide moiety.

16. The compound of claim 15 , wherein R is unsubstituted alkyl or substituted alkyl.

17. The compound of claim 13 , wherein group A is

18. The compound of claim 17 , wherein:

A′ is alkyl or aryl; and

A″ is carboxy alkyl.

19. The compound of claim 13 , wherein group A is

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: IMMUNEXCITE, INC.
To: INNATE BIOTHERAPEUTICS, LLC
Reel/Frame 045465/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2016
From: SIEDLECKI, JAMES MICHAEL; REZNIK, GABRIEL OSCAR; KANE, JOHN JAMES; MIAO, HUA; KLUGE, ARTHUR F.; RUBIN-BEJERANO, IFAT
To: IMMUNEXCITE, INC.
Reel/Frame 040243/0173 →
Continuity (2)
Provisional Application 61990337 · May 8, 2014
Related Publication 20170081428A1 · Mar 23, 2017